First case of refractory colitis caused by Ocrelizumab

Dharma Budi Sunjaya; Cesar Taborda; Rebecca Obeng; Tanvi Dhere

doi:10.1093/ibd/izaa057

First case of refractory colitis caused by Ocrelizumab

Dharma Budi Sunjaya, Cesar Taborda, Rebecca Obeng, Tanvi Dhere^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	E49
Journal	Inflammatory bowel diseases
Volume	26
Issue number	6
DOIs	https://doi.org/10.1093/ibd/izaa057
State	Published - May 12 2020
Externally published	Yes

ASJC Scopus subject areas

Immunology and Allergy
Gastroenterology

Access to Document

10.1093/ibd/izaa057

Cite this

@article{06dd4c9e63054aa8b57ec120a6e6ce2c,

title = "First case of refractory colitis caused by Ocrelizumab",

author = "Sunjaya, {Dharma Budi} and Cesar Taborda and Rebecca Obeng and Tanvi Dhere",

note = "Funding Information: From the *Department of Digestive Diseases, Emory University, Atlanta, GA; †Department of Pathology, Emory University, Atlanta, GA Supported by: There was no grant support provided for this manuscript. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2020",

month = may,

day = "12",

doi = "10.1093/ibd/izaa057",

language = "English (US)",

volume = "26",

pages = "E49",

journal = "Inflammatory Bowel Diseases",

issn = "1078-0998",

publisher = "John Wiley and Sons Inc.",

number = "6",

}

TY - JOUR

T1 - First case of refractory colitis caused by Ocrelizumab

AU - Sunjaya, Dharma Budi

AU - Taborda, Cesar

AU - Obeng, Rebecca

AU - Dhere, Tanvi

N1 - Funding Information: From the *Department of Digestive Diseases, Emory University, Atlanta, GA; †Department of Pathology, Emory University, Atlanta, GA Supported by: There was no grant support provided for this manuscript. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2020/5/12

Y1 - 2020/5/12

UR - http://www.scopus.com/inward/record.url?scp=85084692749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084692749&partnerID=8YFLogxK

U2 - 10.1093/ibd/izaa057

DO - 10.1093/ibd/izaa057

M3 - Letter

C2 - 32198886

AN - SCOPUS:85084692749

VL - 26

SP - E49

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 6

ER -

First case of refractory colitis caused by Ocrelizumab

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this